SRSF1, a splicing factor and a type of RBP, has been reported to be overexpressed in several cancers including glioma, and participates in diverse biological functions, including translation, nonsense-mediated RNA decay, and RNA transport [23–25]. Here, SLU7 is linked to glioma.